| Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies P Maggi, M Absinta, M Grammatico, L Vuolo, G Emmi, G Carlucci, ... Annals of neurology 83 (2), 283-294, 2018 | 206 | 2018 |
| Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients R Iorio, V Damato, A Evoli, M Gessi, S Gaudino, V Di Lazzaro, G Spagni, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 138-146, 2018 | 171 | 2018 |
| Long-lasting rituximab-induced reduction of specific—but not total—IgG4 in MuSK-positive myasthenia gravis M Marino, U Basile, G Spagni, C Napodano, R Iorio, F Gulli, L Todi, ... Frontiers in immunology 11, 613, 2020 | 57 | 2020 |
| An Italian neurology outpatient clinic facing SARS-CoV-2 pandemic: data from 2,167 patients C Piano, E Di Stasio, G Primiano, D Janiri, M Luigetti, G Frisullo, ... Frontiers in Neurology 11, 564, 2020 | 36 | 2020 |
| Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study M Gastaldi, S Mariotto, MP Giannoccaro, R Iorio, M Zoccarato, M Nosadini, ... European Journal of Neurology 27 (4), 633-643, 2020 | 36 | 2020 |
| Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience A Farina, S Falso, S Cornacchini, G Spagni, G Monte, A Mariottini, ... European Journal of Neurology 29 (8), 2505-2510, 2022 | 27 | 2022 |
| Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis V Damato, G Spagni, G Monte, M Woodhall, L Jacobson, S Falso, T Smith, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (9), 995-1000, 2022 | 22 | 2022 |
| Paraneoplastic neurological syndromes R Iorio, G Spagni, G Masi Seminars in diagnostic pathology 36 (4), 279-292, 2019 | 22 | 2019 |
| Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy V Brunetti, G Della Marca, G Spagni, R Iorio Neurology: Neuroimmunology & Neuroinflammation 6 (4), e577, 2019 | 22 | 2019 |
| Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells SM Reincke, N von Wardenburg, MA Homeyer, HC Kornau, G Spagni, ... Cell 186 (23), 5084-5097. e18, 2023 | 17 | 2023 |
| Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic aetiology R Iorio, V Damato, G Spagni, G Della Marca, C Vollono, G Masi, C Papi, ... European Journal of Neurology 27 (10), 2062-2071, 2020 | 15 | 2020 |
| Comparison of fixed and live cell-based assay for the detection of AChR and MuSK antibodies in myasthenia gravis G Spagni, M Gastaldi, P Businaro, Z Chemkhi, C Carrozza, G Mascagna, ... Neurology: Neuroimmunology & Neuroinflammation 10 (1), e200038, 2022 | 14 | 2022 |
| Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? G Monte, G Spagni, V Damato, R Iorio, M Marino, A Evoli Journal of Neurology 268, 1803-1807, 2021 | 13 | 2021 |
| Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis G Spagni, L Todi, G Monte, M Valentini, G Di Sante, V Damato, M Marino, ... Annals of Clinical and Translational Neurology 8 (3), 656-665, 2021 | 13 | 2021 |
| Unprotected stroke management in an undiagnosed case of Severe Acute Respiratory Syndrome Coronavirus 2 infection C Papi, G Spagni, A Alexandre, P Calabresi, G Della Marca, A Broccolini Journal of Stroke and Cerebrovascular Diseases 29 (9), 104981, 2020 | 13 | 2020 |
| Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia V Damato, C Papi, G Spagni, A Evoli, G Silvestri, G Masi, E Sabatelli, ... European journal of neurology 29 (2), 564-572, 2022 | 11 | 2022 |
| Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis G Masi, G Spagni, L Campetella, G Monte, E Sabatelli, A Evoli, C Papi, ... Journal of neuroimmunology 356, 577601, 2021 | 11 | 2021 |
| Heterogeneity in myasthenia gravis: considerations for disease management A Evoli, G Spagni, G Monte, V Damato Expert Review of Clinical Immunology 17 (7), 761-771, 2021 | 11 | 2021 |
| Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review … G Spagni, B Sun, G Monte, E Sechi, R Iorio, A Evoli, V Damato Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 62-69, 2023 | 9 | 2023 |
| Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study A Modoni, A Mastrorosa, G Spagni, A Evoli Clinical Neurophysiology 132 (8), 1845-1849, 2021 | 8 | 2021 |
